Le Lézard
Classified in: Science and technology
Subjects: SVY, SBS

Process Improvers Tame Resistance to Change with No-Code Solutions from Flowfinity


VANCOUVER, BC, Oct. 26, 2023 /PRNewswire/ -- Flowfinity, a trailblazer in no-code application development, is redefining how business analysts can overcome internal resistance to new software solutions. Their award-winning platform, designed with a process improvement mindset, acts as a powerful catalyst to drive digital transformation in the enterprise by empowering business users to deliver innovative applications with less strain on overtaxed IT resources. 

Digital transformation is the key to competitive advantage, yet process improvers often struggle to deliver new business solutions due to resistance to change. Flowfinity experts are now sharing their strategies to turn apprehension into enthusiasm for new solutions. By understanding the psychology behind resistance, you can help users and leaders overcome their fears and build a culture of adaptability that fosters innovation. 

 "We want business analysts to understand that Flowfinity is not just another tool; it's a transformative framework that encourages a cultural shift towards adaptability and continuous improvement," remarks Alex Puttonen, Director of Marketing. "By alleviating concerns regarding disruption, complexity, and cost, businesses can embrace change with reduced risks and increased confidence, all while empowering employees to be drivers of innovation."

The no-code platform leader encourages organizations to transcend the traditional confines of procedural software development and champion a culture where people and technology converge to amplify operational efficiency and unlock a realm of limitless possibilities. 

Flowfinity invites process improvers and business leaders to explore the profound impact of their no-code platform in driving successful digital transformations. Discover how adopting Flowfinity can redefine your organizational landscape, turning challenges into opportunities for innovation and growth. 

To delve deeper into the transformative potential of no-code platforms and to learn how Flowfinity can be the linchpin of your digital strategy, we encourage you to read our insights: How to champion change and accelerate adoption with no-code. 

About Flowfinity

Flowfinity is a no-code platform that empowers the people closest to their real-work business processes to create, automate, and integrate custom applications. For over 20 years, Flowfinity has helped process improvers build flexible, scalable data management applications and workflow automations without committing the time and resources required to write and maintain custom code.

The intuitive no-code platform combines a web-based app editor, SQL database, process automation robots, advanced data collection including IoT data streaming capability, interactive real-time data visualization dashboards, and reliable system integrations.

Media Contact:
Alex Puttonen
604-878.0008 ext 2125
[email protected] 

SOURCE Flowfinity Inc.


These press releases may also interest you

at 09:05
Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)tm solutions, has introduced a new version of the iGlucose, its patented cellular-connected glucose meter used by over 200,000 people with diabetes since 2019. The...

at 09:05
F5 announced that it has been singled out as a visionary in API security for its F5 Distributed Cloud Web App and API Protection (WAAP) in Enterprise Management Associates' Vendor Vision 2024 report. The report highlights "must see" security...

at 08:05
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...

at 08:00
Gateway Fiber's high-speed 100% fiber internet is branching out to...

at 02:34
Elbit Systems Ltd.  ("Elbit Systems" or the "Company") announced today that it was awarded an initial contract of approximately $37 million to supply Iron Fist Active Protection Systems (APS) to General Dynamics Ordnance and Tactical Systems...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...



News published on and distributed by: